March - 2021

Protein Target for Neuroblastoma

Australian researchers have discovered a new way to target an aggressive childhood cancer, neuroblastoma, one of the most common and...

Pediatric cancers have unique genetic vulnerabilities

Most cancer drugs that target specific genetic mutations are designed for adult cancers rather than those in children, partly because ...

ATRT molecular groups: looking at the biology from the clinic

Atypical teratoid rhabdoid tumor (ATRT) is a rare brain tumor that predominantly occurs in young children. Scientists at St. Jude...

Pediatric Cancer Survivors and Diabetes: What Are the Risks?

Diabetes and metabolic syndrome represent two of the most common long-term complications for survivors of childhood cancer. Approximately...

COVID-19 Impacting Caregivers of Children With Cancer

Caregivers of childhood cancer survivors are experiencing changes to medical care, financial disruptions, and emotional distress due to...

Natural "brake" against malignant neuroblastoma

The scientists discovered that the uncontrolled growth of benign neuroblastomas is stopped by a signal molecule produced by Schwann cells...

Origin of childhood cancer malignant rhabdoid tumour discovered

The first proof of the origin of malignant rhabdoid tumour (MRT), a rare childhood cancer, has been discovered by researchers at the ...

Study shows potential of new treatment strategies for most common childhood cancer

Promising target for CAR T cells helps cancer trick the immune system

Palliative Care Important for Young Patients During ‘Identity Development’

Scientists discover new Achilles heel of leukemia cells

Promising investigational therapy improves survival in aggressive childhood brain tumor

Childhood cancer mortality has fallen significantly in the US, but disparities have emerged

St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing

Analysis shows high rate of ‘significant’ health problems in childhood cancer survivors

Fusion oncoprotein forces cell fates toward rhabdomyosarcoma

“DNA loops” in pediatric brain tumors double relapse risk